ABBV vs INCY
AbbVie (ABBV) and Incyte (INCY) compared side by side. AbbVie (ABBV) is larger, with a market cap of $504.8B versus $23.5B for Incyte, about 21.5 times the size. On trailing earnings, INCY is cheaper at 14.7x versus 80.7x for ABBV.
Head to head
| Metric | ABBV | INCY |
|---|---|---|
| Market cap | $504.8B | $23.5B |
| P/E (TTM) | 80.7x | 14.7x |
| Forward P/E | 17.6x | 13.4x |
| Revenue (TTM) | $64.4B | $5.8B |
| Revenue growth | 10.2% | 37.7% |
| Gross margin | 72.8% | 55.7% |
| Operating margin | 40.0% | 41.9% |
| Free cash flow | $18.2B | $1.9B |
| Dividend yield | 2.42% | None |
| 1-year return | +28.9% | +29.6% |
| 5-year return (annual) | +25.6% | +12.0% |
| Max drawdown | -45% | -99% |
| FI Handbook grade | B | B |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$10.0K
$20.0K
20222023202420252026
ABBV vs INCY FAQ
Which is bigger, ABBV or INCY?
AbbVie (ABBV) is larger, with a market cap of $504.8B versus $23.5B for Incyte, about 21.5 times the size.
Is ABBV or INCY cheaper?
On trailing earnings, INCY is cheaper at 14.7x versus 80.7x for ABBV. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABBV or INCY?
INCY returned +29.6% over the past year including dividends, versus +28.9% for ABBV, through October 23, 2026.
Which pays a higher dividend, ABBV or INCY?
ABBV yields 2.42%; INCY does not pay a dividend.